A missense mutation in both hMSH2 and APC in an Ashkenazi Jewish HNPCC kindred: implications for clinical screening.
about
Molecular analysis of hereditary nonpolyposis colorectal cancer in the United States: high mutation detection rate among clinically selected families and characterization of an American founder genomic deletion of the MSH2 gene.The founder mutation MSH2*1906G-->C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish population.Hereditary ovarian carcinoma: heterogeneity, molecular genetics, pathology, and management.A multifactorial likelihood model for MMR gene variant classification incorporating probabilities based on sequence bioinformatics and tumor characteristics: a report from the Colon Cancer Family Registry.Conversion of diploidy to haploidy.ACMG technical standards and guidelines for genetic testing for inherited colorectal cancer (Lynch syndrome, familial adenomatous polyposis, and MYH-associated polyposis).
P2860
A missense mutation in both hMSH2 and APC in an Ashkenazi Jewish HNPCC kindred: implications for clinical screening.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
A missense mutation in both hM ...... ations for clinical screening.
@en
type
label
A missense mutation in both hM ...... ations for clinical screening.
@en
prefLabel
A missense mutation in both hM ...... ations for clinical screening.
@en
P2093
P2860
P356
P1476
A missense mutation in both hM ...... ations for clinical screening.
@en
P2093
C Andreutti-Zaugg
F Manganaro
P2860
P304
P356
10.1136/JMG.36.10.792
P407
P577
1999-10-01T00:00:00Z